知搜-全球专利检索

  1. 登录
  2. 注册
发明授权
CN102058842B 一种治疗中风偏瘫或中风先兆的中药组合物 有权

一种治疗中风偏瘫或中风先兆的中药组合物
摘要：
本发明属于中药组合物的技术领域，具体涉及一种治疗中风偏瘫或中风先兆的中药组合物，其采用如下重量比的原料药制成：黄芪100～130g，赤芍15～30g，水蛭6～12g，川芎10～16g，香附10～20g，鸡血藤20～30g，桃仁15～30g，石菖蒲10～20g，郁金20～30g，威灵仙15～30g，地龙15～30g，胆南星10～20g。本发明主治中风偏瘫、中风先兆。即脑血管疾病为脑血栓形成、脑梗塞、短暂脑缺血、动脉硬化性脑病所致的脑晕欲仆、偏身麻木、半身不遂、语言障碍诸证，总有效率达96.3％。
摘要（英）：

The invention belongs to the technical field of traditional Chinese medicine compositions, and in particular to a traditional Chinese medicine composition for treating hemiplegic apoplexy or premonitory apoplexy. The traditional Chinese medicine composition is prepared from the following bulk pharmaceutical chemicals: 100-130g of Astragalus mongholicus, 15-30g of red peony root, 6-12g of hirudo, 10-16g of szechwan lovage rhizome, 10-20g of nutgrass galingale rhizome, 20-30g of suberect spatholobus stem, 15-30g of peach seed, 10-20g of tatarinow sweetflag rhizome,20-30g of wenchow turmeric root tuber,15-30g of Chinese clematis root and rhizome, 15-30g of earthworm, and 10-20g of bile arisaema. The traditional Chinese medicine composition is mainly used for treating hemiplegic apoplexy or premonitory apoplexy, and relieving symptoms of dizziness, hemianesthesia, hemiplegia and aphasis caused by cerebrovascular diseases such as cerebral thrombosis, cerebral infarction, transient cerebralischemia and arteriosclerotic encephalopathy, and the total effective rate is 96.3%.

公开/授权文献
0/0